These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 18432590)
1. Significant decrease in dialysate albumin concentration during molecular adsorbent recirculating system (M.A.R.S.) therapy. Gong D; Ji D; Ren B; Tao J; Xu B; Ronco C; Li L Int J Artif Organs; 2008 Apr; 31(4):333-9. PubMed ID: 18432590 [TBL] [Abstract][Full Text] [Related]
2. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264 [TBL] [Abstract][Full Text] [Related]
3. Depurative capacity of molecular adsorbent recycling system (MARS): A focus on bilirubin removal. Gong D; Cruz D; Ronco C Int J Artif Organs; 2008 Oct; 31(10):875-81. PubMed ID: 19009505 [TBL] [Abstract][Full Text] [Related]
4. Albumin dialysis molecular adsorbents recirculating system: impact of dialysate albumin concentration on detoxification efficacy. Drexler K; Baustian C; Richter G; Ludwig J; Ramlow W; Mitzner S Ther Apher Dial; 2009 Oct; 13(5):393-8. PubMed ID: 19788455 [TBL] [Abstract][Full Text] [Related]
5. Albumin dialysis without anticoagulation in high-risk patients: an observational study. Tan HK; Yang WS; Choong HL; Wong KS Artif Organs; 2012 Mar; 36(3):E83-8. PubMed ID: 21091517 [TBL] [Abstract][Full Text] [Related]
6. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial. Wallon G; Guth C; Guichon C; Thevenon S; Gazon M; Viale JP; Schoeffler M; Duperret S; Aubrun F Blood Purif; 2022; 51(3):243-250. PubMed ID: 34139706 [TBL] [Abstract][Full Text] [Related]
7. Hypoglycemia in nondiabetic patients undergoing albumin dialysis by molecular adsorbent recirculating system. Khoo AL; Tham LS; Lim GK; Lee KH Liver Transpl; 2003 Sep; 9(9):949-53. PubMed ID: 12942456 [TBL] [Abstract][Full Text] [Related]
8. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure]. Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917 [TBL] [Abstract][Full Text] [Related]
9. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin. Lee KH; Wendon J; Lee M; Da Costa M; Lim SG; Tan KC Liver Transpl; 2002 Jul; 8(7):591-3. PubMed ID: 12089711 [TBL] [Abstract][Full Text] [Related]
10. Albumin dialysis: single pass vs. recirculation (MARS). Peszynski P; Klammt S; Peters E; Mitzner S; Stange J; Schmidt R Liver; 2002; 22 Suppl 2():40-2. PubMed ID: 12220302 [TBL] [Abstract][Full Text] [Related]
11. First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock. El Banayosy A; Kizner L; Schueler V; Bergmeier S; Cobaugh D; Koerfer R ASAIO J; 2004; 50(4):332-7. PubMed ID: 15307543 [TBL] [Abstract][Full Text] [Related]
12. Development of high-efficiency molecular adsorbent recirculating system: preliminary report. Marangoni R; Bellati G; Castelli A; Romagnoli E Artif Organs; 2014 Oct; 38(10):879-83. PubMed ID: 24392970 [TBL] [Abstract][Full Text] [Related]
13. Effective bilirubin reduction by single-pass albumin dialysis in liver failure. Boonsrirat U; Tiranathanagul K; Srisawat N; Susantitaphong P; Komolmit P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S Artif Organs; 2009 Aug; 33(8):648-53. PubMed ID: 19624591 [TBL] [Abstract][Full Text] [Related]
14. Single Pass Albumin Dialysis-A Dose-Finding Study to Define Optimal Albumin Concentration and Dialysate Flow. Schmuck RB; Nawrot GH; Fikatas P; Reutzel-Selke A; Pratschke J; Sauer IM Artif Organs; 2017 Feb; 41(2):153-161. PubMed ID: 27121702 [TBL] [Abstract][Full Text] [Related]
15. Increase of octanoate concentrations during extracorporeal albumin dialysis treatments. Klammt S; Koball S; Hickstein H; Gloger M; Henschel J; Mitzner S; Stange J; Reisinger EC Ther Apher Dial; 2009 Oct; 13(5):437-43. PubMed ID: 19788462 [TBL] [Abstract][Full Text] [Related]
16. MARS therapy in critically ill patients with advanced malignancy: a clinical and technical report. Tan HK; Lim JS; Tan CK; Ng HS; Chow P; Lui HF; Wong GC; Tan PH; Raghuram J; Ng HN; Choong LH; Wong KS; Woo KT Liver Int; 2003; 23 Suppl 3():52-60. PubMed ID: 12950962 [TBL] [Abstract][Full Text] [Related]
17. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386 [TBL] [Abstract][Full Text] [Related]
18. The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure. Sen S; Jalan R Perfusion; 2004; 19 Suppl 1():S43-8. PubMed ID: 15161063 [TBL] [Abstract][Full Text] [Related]
19. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease. Sen S; Felldin M; Steiner C; Larsson B; Gillett GT; Olausson M; Williams R; Jalan R Liver Transpl; 2002 Oct; 8(10):962-7. PubMed ID: 12360442 [TBL] [Abstract][Full Text] [Related]
20. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study. Sponholz C; Matthes K; Rupp D; Backaus W; Klammt S; Karailieva D; Bauschke A; Settmacher U; Kohl M; Clemens MG; Mitzner S; Bauer M; Kortgen A Crit Care; 2016 Jan; 20():2. PubMed ID: 26728364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]